Cannabidiol has a wide range of applications, and Europe and the United States are the main consumer regions in the world.

Cannabidiol, referred to as CBD, is a chemical substance with the molecular formula C21H30O2. It appears as white to light yellow resin or crystal. It is almost insoluble in water and soluble in organic solvents such as ethanol, methanol, ether, benzene, and chloroform. Cannabidiol is widely present in cannabis plants and is a chemical raw material with a variety of pharmacological effects and effects. It is widely used in food, medicine, cosmetics and other fields.

Cannabidiol has anti-inflammatory, bactericidal, analgesic, anti-aging, antioxidant, anti-anxiety, antipsychotic, neuroprotective, cardiovascular protective and other effects. In the medical field, it can be used as anti-epileptic drugs, analgesic and anti-inflammatory drugs, elderly Drug R&D and production scenarios such as dementia drugs, anxiety drugs, and autoimmune disease drugs; in the food field, cannabidiol can be used in soft drinks and snack food production scenarios; in the cosmetics field, cannabidiol relies on its anti-aging and antioxidant properties As well as autoimmune effects, it can be used in the production of skin care products for acne removal and inflammation relief.

According to the “2023-2028 cannabidiol (CBD) industry market in-depth research and investment prospect forecast analysis report2023-2028 span>” shows that the global cannabidiol market size will be approximately US$460 million in 2022, a year-on-year growth of 3.1%. In recent years, with the continuous in-depth research on cannabidiol, its application fields are gradually expanding, and it is also used in sports, entertainment and other fields. There is broad room for market development in the future.

Globally, the major companies in the cannabidiol market include Folium Biosciences, Charlotte’s Web, CV Sciences, Medical Marijuana, Kazmira, CW Hemp/CW Botanicals, Freedom Leaf and other international companies, as well as Hemp Group, Yunnan Tairui Biotechnology, Ming. Chinese companies such as Gao Biotechnology, Shouxiangu Pharmaceutical Co., Ltd., Lingebei Cold Zone Biotechnology, Dinghengsheng Pharmaceutical, Hengbo Innovative Hemp Biotechnology, etc.

At present, the global cannabidiol market is still mainly concentrated in developed countries in Europe and the United States. The main reason is that developed countries in Europe and the United States, such as the United States, France, Germany, Canada, etc., have taken the lead in fully legalizing cannabis, and at the same time, the relevant laws and policies are relatively weak. The size of my country’s cannabidiol market is still relatively small, and the industry has not yet entered a stage of rapid development. The main reason is that my country’s supervision of cannabidiol is relatively strong. For example, in May 2021, the State Food and Drug Administration updated the catalog of banned raw materials for cosmetics and included cannabidiol. Officially included in the list of banned raw materials for cosmetics.

Industry analysts said that my country is the world’s major producer of industrial hemp, and sufficient supply of raw materials will continue to benefit Cannabidiol Industry Development. At present, cannabidiol in my country is mainly prepared through purification methods, which refers to the method of using industrial hemp as raw material, ethanol and water as solvents, and obtaining cannabidiol through extraction, water extraction, distillation, separation, purification and other links. Industrial hemp is a key raw material for the production of cannabidiol, and its domestic output will exceed 100,000 tons in 2022.